FDA Drug Application (010040) for RENOVIST II by BRACCO

Back to FDA Applications sponsored by BRACCO

Application Number010040
Product Number019
FormINJECTABLE;INJECTION
Dosage28.5%;29.1%
Product Market Status Discontinued
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameRENOVIST II
Active IngredientDIATRIZOATE MEGLUMINE; DIATRIZOATE SODIUM

Active IngredientCount
List of drugs with Active Ingredient DIATRIZOATE MEGLUMINE31
List of drugs with Active Ingredient DIATRIZOATE SODIUM21


Back to FDA Applications sponsored by BRACCO